The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
Clinical trial NCT07287228 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07287228
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2027-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.